Conceptualization / Study design: AH, AE, DOC, and AV. Data analysis and interpretation: AH, AE, DOC, AMo, and LJ. Provision of patients/study materials & data collection/curation: AH, AMi, AE, SB, KB, ACa, KC, PC, IE, MG, LG, NH, DI, GJ, KL, MM, AMa, BM, JM, EN, KP, SR, GT, ST, LEH, SC, LJ, DBh, PAB, SPH, MLL, FvD, SG, and DOC. Manuscript writing and review: All authors. Final approval of manuscript: All authors.
Trending
- Relapsed childhood cancers show genomic scars left by previous therapy
- Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma
- Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer
- Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma
- SETD8-mediated mono-methylation of YAP at K76 promotes K48-linked polyubiquitination and degradation to suppress colorectal cancer
- Weighing the Catabolic Effects of Lenvatinib/Everolimus vs SOC in ccRCC
- How Did KRAS Become an Actionable Target in Oncology?
- Tumor-derived annexin A1 drives lenvatinib resistance by regulating SOX2/STAT3/S100A6 feedback loop and M2 macrophage polarization in hepatocellular carcinoma

